Compounded semaglutide: Similar beyond-use dates to compounded tirzepatide, typically 28 to 60 days depending on the pharmacy and formulation
Subgroup analyses on the association of GLP-1 RAs use with the incidence of sudden cardiac death
These formulations are prepared by licensed compounding pharmacies using active ingredients sourced from FDA-registered manufacturers and dispensed under a clinicians prescription

Use an Ozempic Lawsuit Claim When: You used Ozempic, Wegovy, or another GLP-1 drug for at least 30 days You were diagnosed with gastroparesis, intestinal obstruction, or severe GI conditions after starting the drug Your diagnosis was confirmed by a physician with documented medical records Your injury required hospitalization, surgery, or ongoing medical treatment You were not adequately warned by your physician or the drug's labeling of the specific risks involved Do Not Expect to Qualify If: Your only symptoms were the mild nausea described as expected in the drug's labeling You stopped the drug voluntarily with no lasting injury You have no medical documentation of your diagnosis or treatment Your statute of limitations has already expired (consult an attorney immediately to verify) The injuries you experienced are not supported by existing medical and scientific literature related to GLP-1 drugs Situation: A patient in her mid-40s was prescribed Ozempic off-label for weight loss by her primary care physician in early 2023

Hydration status: Nausea and reduced oral intake can lead to dehydration, potentially causing acute kidney injury, particularly in older adults